Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

NOVOMIX™ 30 FLEXPEN suspension for subcutaneous injection 100U/ml (3ml), cartridges in pen injectors 5pcs

🔥 3 items sold in last 3 hours
12 people are viewing this product
Active Ingredient:

Manufacturer:

$135.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

L-THYROXINE BERLIN CHEMIE™ tablets 100mcg, 100pcs

$10.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

Analogs of NOVOMIX™ 30 FLEXPEN

L-THYROXINE BERLIN CHEMIE™ tablets 100mcg, 100pcs

$10.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

OLEOS SUPERCHISTOTEL™ solution 5ml, 1pc

$11.00
Add to cart

ABAKTAL™ tablets 400mg, 10pcs

$42.00
Add to cart

Table of Contents

NOVOMIX™ 30 FLEXPEN 100U Suspension 3ml Buy Online

NovoMix 30 FlexPen: A Comprehensive Overview

Managing diabetes effectively requires a reliable and convenient insulin delivery system. NovoMix 30 FlexPen offers a precise and user-friendly solution for individuals with type 1 or type 2 diabetes needing insulin therapy. Its pre-filled design simplifies the administration process, making it easier to maintain consistent blood sugar levels.

This article provides a comprehensive overview of NovoMix 30 FlexPen, exploring its mechanism of action, dosage, benefits, and potential drawbacks. Understanding these aspects is crucial for patients to successfully manage their diabetes and achieve optimal health outcomes.

NovoMix 30 FlexPen is a biphasic insulin aspart formulation. This means it contains a mixture of fast-acting (soluble) and intermediate-acting (crystalline) insulin aspart, providing both immediate and extended glucose control. The precise blend ensures a more balanced blood sugar profile throughout the day.

What is NovoMix 30 FlexPen?

NovoMix 30 FlexPen is a pre-filled pen injector containing a biphasic insulin aspart suspension. This innovative delivery system offers a convenient and precise method for administering insulin to manage blood glucose levels in individuals with diabetes. The pen’s design facilitates accurate dosing, minimizing the risk of errors commonly associated with traditional insulin injection methods.

The biphasic nature of NovoMix 30 means it comprises both a fast-acting soluble component and an intermediate-acting crystalline component. This unique combination allows for a more balanced and sustained control of blood sugar levels, compared to using only a fast-acting or intermediate-acting insulin alone. The formulation is designed for subcutaneous injection, providing a relatively rapid onset of action with a duration of effect suitable for mealtime and basal insulin needs.

Each FlexPen contains five 3ml cartridges, each delivering 100 units of insulin aspart per milliliter. The pen injector itself features a dose selector allowing for precise adjustments in one-unit increments, making it suitable for individualized treatment plans. This system offers a significant improvement in convenience and accuracy for patients requiring insulin therapy.

Mechanism of Action

NovoMix 30 FlexPen’s hypoglycemic effect stems from its biphasic insulin aspart composition. The soluble insulin aspart component rapidly lowers blood glucose levels by facilitating glucose uptake into muscle and fat cells, while simultaneously suppressing glucose production in the liver. This rapid action makes it ideal for managing post-meal glucose spikes.

The crystalline insulin aspart component provides a more prolonged glucose-lowering effect. This extended action helps maintain stable blood sugar levels between meals and overnight, preventing significant fluctuations that can be detrimental to overall health. The combination of fast and intermediate-acting insulins provides a more balanced and sustained control compared to using only one type of insulin.

The insulin molecules bind to specific receptors on the surface of cells, triggering a cascade of intracellular events that ultimately lead to glucose transport. This process is essential for maintaining glucose homeostasis and preventing the complications associated with poorly managed diabetes. The precise ratio of soluble and crystalline insulin aspart in NovoMix 30 is carefully formulated to optimize this dual action for effective blood sugar control.

Dosage and Administration

NovoMix 30 FlexPen is designed for subcutaneous injection only. Intravenous administration is strictly contraindicated due to the potential for severe hypoglycemic reactions. The specific dosage regimen is determined by a healthcare professional based on individual needs and blood glucose monitoring. Careful adherence to prescribed dosage is essential for effective diabetes management and minimizing adverse effects.

The recommended injection sites include the abdomen, thigh, or upper arm. Rotating injection sites helps prevent lipohypertrophy (fat buildup) at the injection site, which can impair insulin absorption. Before administering the injection, ensure the medication has reached room temperature to enhance comfort and absorption. The medication should be injected immediately before or after a meal, as determined by your doctor.

The NovoMix 30 FlexPen features a dose selector that allows for precise insulin delivery in one-unit increments. Always ensure the correct dose is selected before administering the injection. After the injection, hold the pen in place for a few seconds to ensure complete delivery of the insulin. Proper injection technique is crucial for maximizing the therapeutic benefits and minimizing the risk of complications. Patients should receive thorough training on the proper use of the pen injector.

Benefits of NovoMix 30 FlexPen

NovoMix 30 FlexPen offers several key advantages for individuals managing their diabetes. Its biphasic formulation provides both rapid and prolonged glucose control, helping to maintain stable blood sugar levels throughout the day and night. This balanced approach contributes to better overall health and reduces the risk of long-term complications associated with fluctuating blood sugar.

The pre-filled pen injector design significantly enhances convenience and ease of use. The dose selector allows for precise insulin delivery, minimizing errors and ensuring accurate dosing. This feature is particularly beneficial for patients who find traditional insulin injection methods challenging or cumbersome. The pre-filled nature eliminates the need for mixing insulin, simplifying the administration process.

Furthermore, the compact and portable design of the FlexPen makes it ideal for individuals with active lifestyles. Its discreet nature allows for easy and convenient insulin administration in various settings, promoting better adherence to the prescribed treatment regimen. The overall user-friendliness of the NovoMix 30 FlexPen contributes to improved patient compliance and better diabetes management outcomes.

Pros

  • Convenient and easy to use: The pre-filled pen injector simplifies insulin administration, eliminating the need for mixing and reducing the risk of dosing errors. Its user-friendly design promotes better patient compliance and ease of use, especially for individuals who may find traditional injection methods challenging.
  • Precise dosing: The dose selector allows for accurate insulin delivery in one-unit increments, enabling personalized treatment plans and minimizing the risk of hypo- or hyperglycemia. This enhanced precision contributes to better blood glucose control and improved overall health.
  • Balanced blood glucose control: The biphasic insulin aspart formulation provides both rapid and prolonged glucose-lowering effects, resulting in more stable blood sugar levels throughout the day. This balanced approach helps minimize fluctuations and reduces the likelihood of both short-term and long-term complications.
  • Portability and discretion: The compact and portable design of the FlexPen makes it ideal for individuals with active lifestyles. Its discreet size allows for easy and convenient insulin administration in various settings without drawing undue attention. This enhances the patient’s ability to manage their condition effectively regardless of their location or activity.

Potential Drawbacks

While NovoMix 30 FlexPen offers numerous benefits, potential drawbacks should be considered. As with all insulin therapies, the risk of hypoglycemia (low blood sugar) exists, particularly if the dose is too high or if meals are skipped or delayed. Careful blood glucose monitoring and adherence to the prescribed treatment plan are crucial to minimize this risk. Patients should be aware of the symptoms of hypoglycemia and have a plan in place to address them promptly.

Another potential issue is the risk of injection site reactions, such as redness, swelling, or itching. Rotating injection sites and using proper injection techniques can help minimize these reactions. While generally mild and transient, these reactions should be reported to a healthcare professional if they become persistent or severe. Patients should be educated on proper injection techniques to minimize discomfort and side effects.

Furthermore, individual responses to insulin therapy can vary. Some individuals may experience weight gain as a side effect of insulin treatment. Dietary adjustments and regular exercise can help mitigate this potential effect. Close monitoring by a healthcare provider is essential to adjust dosage and manage any weight-related concerns. Regular follow-up appointments are crucial to ensure the effectiveness and safety of the treatment.

Cons

  • Hypoglycemia Risk: A significant potential drawback is the risk of hypoglycemia (low blood sugar), especially if the dose is incorrect or if meals are missed or delayed. Careful monitoring of blood glucose levels and adherence to the prescribed treatment plan are essential to mitigate this risk. Patients must be educated on recognizing and treating hypoglycemic episodes.
  • Injection Site Reactions: Some individuals may experience injection site reactions, such as redness, swelling, or itching. While usually mild and temporary, these reactions can be uncomfortable. Rotating injection sites and employing proper injection techniques can help minimize the occurrence and severity of these reactions. Patients should report persistent or severe reactions to their healthcare provider.
  • Weight Gain: Weight gain is a potential side effect of insulin therapy, although this can often be managed through diet and exercise. Regular monitoring and adjustments to the treatment plan, in consultation with a healthcare professional, are necessary to address this concern effectively. Lifestyle modifications can play a crucial role in managing weight.
  • Individual Variability: Responses to insulin therapy can vary significantly from person to person. What works well for one patient may not be as effective for another. Close monitoring and regular adjustments to the dosage and treatment regimen, under the guidance of a healthcare professional, are crucial to optimize individual results.

Onset and Peak Effects

Understanding the onset and peak effects of NovoMix 30 FlexPen is crucial for effective diabetes management. Due to its biphasic nature, the insulin exhibits a rapid onset of action, typically within 10-20 minutes after subcutaneous injection. This rapid onset allows for effective control of post-meal glucose elevations, preventing significant blood sugar spikes.

The peak effect of NovoMix 30 usually occurs between 1 and 4 hours post-injection. This peak represents the period of maximum insulin activity, during which the blood glucose-lowering effect is most pronounced. Knowing the peak time allows patients to time their meals and snacks appropriately to avoid hypoglycemic episodes. This timing is essential for optimizing the therapeutic benefits of the medication and maintaining stable blood sugar levels.

The duration of action extends beyond the peak effect, providing a more sustained glucose control compared to fast-acting insulins alone. This extended effect helps maintain stable blood sugar levels between meals and overnight, reducing the risk of significant fluctuations. The combined rapid onset and prolonged duration of action make NovoMix 30 a versatile option for managing both mealtime and basal insulin requirements. Precise timing relative to meals is crucial to avoid hypoglycemia.

Important Considerations

Regular blood glucose monitoring is essential for effective diabetes management while using NovoMix 30 FlexPen. Frequent testing helps determine the appropriate insulin dose and allows for timely adjustments to maintain optimal blood sugar levels. Patients should be educated on proper blood glucose monitoring techniques and should understand how to interpret their results.

Dietary adjustments may be necessary to optimize the effectiveness of NovoMix 30 FlexPen. A balanced diet, rich in fruits, vegetables, and whole grains, helps maintain stable blood sugar levels. Patients should consult with a registered dietitian or certified diabetes educator to create an individualized meal plan that complements their insulin regimen. Understanding carbohydrate counting and its impact on blood sugar is crucial.

Regular exercise plays a vital role in overall health and diabetes management. Physical activity improves insulin sensitivity, helping to lower blood glucose levels. Patients should engage in regular physical activity as recommended by their healthcare provider. Combining regular exercise with a balanced diet and appropriate insulin dosing enhances the effectiveness of the treatment and improves overall well-being. Consult your doctor before starting any new exercise program.

Additional Information

Before initiating NovoMix 30 FlexPen therapy, a thorough assessment of the patient’s overall health status, including kidney and liver function, is crucial. Pre-existing conditions can influence insulin requirements and the potential for adverse effects. This comprehensive evaluation helps ensure the safety and efficacy of the treatment and allows for personalized adjustments to the dosage and treatment plan.

Patients should be aware of potential drug interactions. Concomitant use of certain medications, such as beta-blockers or some oral hypoglycemic agents, can affect insulin requirements and increase the risk of hypoglycemia. A detailed medication history should be provided to the healthcare professional to assess for potential interactions and guide appropriate dose adjustments. Open communication with your healthcare provider is vital.

Proper disposal of used NovoMix 30 FlexPen cartridges is important for safety and environmental reasons. Follow the guidelines provided by your healthcare provider or local waste management authorities for safe disposal. Never reuse or share insulin pens or cartridges. Adherence to proper disposal practices helps prevent accidental needle-stick injuries and protects the environment.

  • Novomix™ 30 Flexpen Suspension For Subcutaneous Injection 100U/Ml (3Ml), Cartridges In Pen Injectors 5Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Novomix™ 30 Flexpen Suspension For Subcutaneous Injection 100U/Ml (3Ml), Cartridges In Pen Injectors 5Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Novomix™ 30 Flexpen Suspension For Subcutaneous Injection 100U/Ml (3Ml), Cartridges In Pen Injectors 5Pcs Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “NOVOMIX™ 30 FLEXPEN suspension for subcutaneous injection 100U/ml (3ml), cartridges in pen injectors 5pcs”

Your email address will not be published. Required fields are marked

Similar products

HUMALOG™ MIX 50 suspension for subcutaneous injection 100IU/ml (3ml), 5 cartridges with QuickPen

$121.00
Add to cart

RINSULIN™ R solution for injection 100IU/ml (10ml), vial 1pc

$33.00
Add to cart

NOVORAPID™ FLEXPEN solution for injection 100U/ml (3ml), cartridges in pre-filled pens 5pcs

$127.00
Add to cart

BIOSULIN™ R solution for injection 100IU/ml (10ml), vial 1pc

$38.00
Add to cart

BIOSULIN™ R solution for injection 100IU/ml (3ml), cartridges 5pcs

$69.00
Add to cart

BIOSULIN™ R solution for injection 100IU/ml (3ml), cartridges in BIOMATICPEN pens 5pcs

$102.00
Add to cart

ACTRAPID™ HM injection solution 100IU/ml (10ml), vial 1pc

$31.00
Add to cart
Select your currency